DRUG

Bright Minds Biosciences
DRUG

Overview Fund Trends Analyst Outlook Journalist POV

31 hedge funds and large institutions have $176M invested in Bright Minds Biosciences in 2024 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
31
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$38.2M
2
+$18.4M
3
+$18M
4
RCM
RA Capital Management
Massachusetts
+$16.6M
5
SCM
Sio Capital Management
New York
+$16.3M

Top Sellers

1
-$6.46M
2
-$175K
3
-$117
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$38.2M
2
$18.4M
3
$18M
4
$16.6M
5
$16.3M
6
$14.5M
7
$9.06M
8
$8.82M
9
$6.04M
10
$5.48M
11
$4.87M
12
$4.77M
13
$3.72M
14
$2.49M
15
$2.46M
16
$2.18M
17
$1.61M
18
$1.45M
19
$540K
20
$366K
21
$238K
22
$173K
23
$111K
24
$29K
25
$6.3K
1
2